Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Typhoid (bivalent) vaccine by Serum Institute of India for Typhoid Fever: Likelihood of Approval
Typhoid (bivalent) vaccine is under clinical development by Serum Institute of India and currently in Phase I for Typhoid Fever....
JNJ-8543 by Johnson & Johnson for Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
JNJ-8543 is under clinical development by Johnson & Johnson and currently in Phase I for Chronic Lymphocytic Leukemia (CLL). According...
D3L-001 by D3 Bio for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer): Likelihood of Approval
D3L-001 is under clinical development by D3 Bio and currently in Phase I for Human Epidermal Growth Factor Receptor 2...
D3L-001 by D3 Bio for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval
D3L-001 is under clinical development by D3 Bio and currently in Phase I for Gastroesophageal (GE) Junction Carcinomas. According to...
D3L-001 by D3 Bio for Gastric Cancer: Likelihood of Approval
D3L-001 is under clinical development by D3 Bio and currently in Phase I for Gastric Cancer. According to GlobalData, Phase...
Donepezil by Inventage Lab for Alzheimer's Disease: Likelihood of Approval
Donepezil is under clinical development by Inventage Lab and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase...
Bis-5 by L&L Biopharma for Endometrial Cancer: Likelihood of Approval
Bis-5 is under clinical development by L&L Biopharma and currently in Phase I for Endometrial Cancer. According to GlobalData, Phase...
Bis-5 by L&L Biopharma for Solid Tumor: Likelihood of Approval
Bis-5 is under clinical development by L&L Biopharma and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
IBI-363 by Innovent Biologics for Solid Tumor: Likelihood of Approval
IBI-363 is under clinical development by Innovent Biologics and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
PRAX-628 by Praxis Precision Medicines for Epilepsy: Likelihood of Approval
PRAX-628 is under clinical development by Praxis Precision Medicines and currently in Phase II for Epilepsy. According to GlobalData, Phase...
LM-108 by LaNova Medicines for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
LM-108 is under clinical development by LaNova Medicines and currently in Phase II for Triple-Negative Breast Cancer (TNBC). According to...
SCG-101 by SCG Cell Therapy for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
SCG-101 is under clinical development by SCG Cell Therapy and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma). According...
MRT-2359 by Monte Rosa Therapeutics for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
MRT-2359 is under clinical development by Monte Rosa Therapeutics and currently in Phase II for Human Epidermal Growth Factor Receptor...
KYV-101 by Kyverna Therapeutics for Primary Progressive Multiple Sclerosis (PPMS): Likelihood of Approval
KYV-101 is under clinical development by Kyverna Therapeutics and currently in Phase II for Primary Progressive Multiple Sclerosis (PPMS). According...
KYV-101 by Kyverna Therapeutics for Secondary Progressive Multiple Sclerosis (SPMS): Likelihood of Approval
KYV-101 is under clinical development by Kyverna Therapeutics and currently in Phase II for Secondary Progressive Multiple Sclerosis (SPMS). According...
KYV-101 by Kyverna Therapeutics for Myasthenia Gravis: Likelihood of Approval
KYV-101 is under clinical development by Kyverna Therapeutics and currently in Phase II for Myasthenia Gravis. According to GlobalData, Phase...
Thiostrepton by RS Oncology for Non-Small Cell Lung Cancer: Likelihood of Approval
Thiostrepton is under clinical development by RS Oncology and currently in Phase II for Non-Small Cell Lung Cancer. According to...
BioGam by Microgen for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura): Likelihood of Approval
BioGam is under clinical development by Microgen and currently in Phase III for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura). According...
Aflibercept biosimilar by Alvotech for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
Aflibercept biosimilar is under clinical development by Alvotech and currently in Phase III for Wet (Neovascular / Exudative) Macular Degeneration....
Lysergic acid diethylamide by MindBio Therapeutics for Major Depressive Disorder: Likelihood of Approval
Lysergic acid diethylamide is under clinical development by MindBio Therapeutics and currently in Phase II for Major Depressive Disorder. According...